Outsmarting cancer with tumor data and machine learning
Gordion Bioscience is a biotech company developing better cancer drugs by uniquely integrating patient selection into the target identification stage. Using real patient tumor whole genome data — including both exome and dark genome alterations — Gordion identifies novel drug targets that are invisible in cell line-based assays. Their machine learning platform combines cohort selection with target identification into a single coherent strategy, enabling more precise and effective oncology drug development.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Klick Health is a healthcare marketing and commercialization agency serving life sciences and pha...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
